Protective effects of alpha-hederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes

被引:54
作者
AmaraMokrane, YA
LehucherMichel, MP
Balansard, G
Dumenil, G
Botta, A
机构
[1] Lab. de Biogénotoxicologie, Serv. de Médecine du Travail, Faculté de Médecine, 1.3385 Cedex 05
[2] Lab. Microbiologie-Lab. P., Faculté de Pharmacie, 1.3385 Cedex 05
关键词
D O I
10.1093/mutage/11.2.161
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The influence of alpha-hederin (a saponin isolated from Hedera helix), chlorophyllin, the sodium-copper salt of chlorophyll, and ascorbic acid (vitamin C) on the direct clastogenicity of doxorubicin (Adriamycin (R)) was investigated in vitro in human lymphocytes for the induction of micronuclei, In order to determine a possible mechanism of action responsible for the antimutagenic activity, treatments were performed for the three substances at different times of the culture (pre-treatment, simultaneous and post-treatment). Alpha-hederin (1.3 x 10(-2), 0.13, 1.3 and 13 nmol/ml) and chlorophyllin (0.14, 1.4 and 14 nmol/ml) were found to exert an antimutagenic effect against the clastogenicity of doxorubicin (1.5 x 10(-2) nmol/ml) in all treatments at all concentrations, Ascorbic acid (10 nmol/ml) was effective in reducing the micronucleus levels only in the simultaneous treatment, when it was previously incubated with doxorubicin for 2 h at 37 degrees C before being introduced into the culture, Our results suggested a desmutagenic effect for alpha-hederin, chlorophyllin and ascorbic acid, Chlorophyllin acted also through a bio-antimutagenic mechanism and alpha-hederin seemed to induce metabolic enzymes, which inactivated doxorubicin, Preliminary studies showed that the effective antimutagenic concentrations of alpha-hederin, chlorophyllin and ascorbic acid had no clastogenic or aneugenic effects in human lymphocytes, No cytotoxicity was observed for the three antimutagenic agents either.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 40 条
[1]  
AMARAMOKRANE YA, 1995, MED SCI RES, V23, P183
[2]   DIETARY CARCINOGENS AND ANTICARCINOGENS - OXYGEN RADICALS AND DEGENERATIVE DISEASES [J].
AMES, BN .
SCIENCE, 1983, 221 (4617) :1256-1264
[3]   INHIBITORY EFFECT OF HEMIN ON THE MUTAGENIC ACTIVITIES OF CARCINOGENS [J].
ARIMOTO, S ;
NEGISHI, T ;
HAYATSU, H .
CANCER LETTERS, 1980, 11 (01) :29-33
[4]   ROLE OF HEMIN IN THE INHIBITION OF MUTAGENIC ACTIVITY OF 3-AMINO-1-METHYL-5H-PYRIDO[4,3-B]INDOLE (TRP-P-2) AND OTHER AMINOAZAARENES [J].
ARIMOTO, S ;
HAYATSU, H .
MUTATION RESEARCH, 1989, 213 (02) :217-226
[5]   BINDING OF POLYCYCLIC PLANAR MUTAGENS TO CHLOROPHYLLIN RESULTING IN INHIBITION OF THE MUTAGENIC ACTIVITY [J].
ARIMOTO, S ;
FUKUOKA, S ;
ITOME, C ;
NAKANO, H ;
RAI, H ;
HAYATSU, H .
MUTATION RESEARCH, 1993, 287 (02) :293-305
[6]  
BALANSARD G, 1980, PLANTA MED, V39, P234
[7]  
BRONZETTI G, 1990, ANTIMUTAGENESIS ANTI, V2, P463
[9]   CHEMOPREVENTIVE PROPERTIES OF CHLOROPHYLLIN - INHIBITION OF AFLATOXIN-B1 (AFB1)-DNA BINDING INVIVO AND ANTIMUTAGENIC ACTIVITY AGAINST AFB1 AND 2 HETEROCYCLIC AMINES IN THE SALMONELLA MUTAGENICITY ASSAY [J].
DASHWOOD, RH ;
BREINHOLT, V ;
BAILEY, GS .
CARCINOGENESIS, 1991, 12 (05) :939-942
[10]   MECHANISMS OF INHIBITORS OF MUTAGENESIS AND CARCINOGENESIS - CLASSIFICATION AND OVERVIEW [J].
DEFLORA, S ;
RAMEL, C .
MUTATION RESEARCH, 1988, 202 (02) :285-306